Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
Forte Biosciences Cash from Operations (Annual) : -50.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -50.88M |
| December 31, 2024 | -30.74M |
| December 31, 2023 | -28.71M |
| December 31, 2022 | -8.185M |
| December 31, 2021 | -16.68M |
| December 31, 2020 | -18.42M |
| Date | Value |
|---|---|
| December 31, 2019 | -2.771M |
| December 31, 2018 | -34.47M |
| December 31, 2017 | -31.13M |
| December 31, 2016 | -29.54M |
| December 31, 2015 | -21.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| argenx SE | 850.49M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |